Literature DB >> 26852755

Cluster Headache as the Index Event in MS: A Case Report.

Jonathan Benjamin Pelikan1, Jennifer A McCombe2, Trevor Kotylak3, Werner J Becker4.   

Abstract

We report a 42-year-old woman who presented with cluster headache (CH) in association with other neurological symptoms as the index event of new onset multiple sclerosis (MS). Her initial symptoms were left-sided headache with ipsilateral lacrimation and nasal congestion associated with ipsilateral facial numbness. A subsequent similar headache attack was also associated with ipsilateral arm ataxia and gait ataxia. She had many additional short headache attacks without focal neurological symptoms. Her cluster-like headache attacks have not recurred since intiation of dimethyl fumarate. Our patient illustrates that cluster-like headache attacks can occur as a first symptom of MS, in our patient in association with other neurological symptoms. A striking finding in our patient was a large demyelinating lesion in the brachium pontis ipsilateral to the headaches, although additional supratentorial demyelinating lesions were also present. Although CH associated with MS is rare, our patient and the two other reported patients with MS and CH with similar ipsilateral brachium pontis lesions suggest that the lesions in this location may have played a role in the generation of the cluster-like attacks.
© 2016 American Headache Society.

Entities:  

Keywords:  brachium pontis; cluster headache; multiple sclerosis

Mesh:

Year:  2016        PMID: 26852755     DOI: 10.1111/head.12768

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  2 in total

1.  The epidemiology of primary headaches in patients with multiple sclerosis.

Authors:  Long Wang; Juan Zhang; Zi-Ru Deng; Mei-Dan Zu; Yu Wang
Journal:  Brain Behav       Date:  2020-12-08       Impact factor: 2.708

Review 2.  Secondary (Symptomatic) Trigeminal Autonomic Cephalalgia.

Authors:  Debashish Chowdhury
Journal:  Ann Indian Acad Neurol       Date:  2018-04       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.